PWP
PACB icon

Private Wealth Partners’s Pacific Biosciences PACB Stock Holding History

Private Wealth Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33K Hold
25,000
– – ﹤0.01% 169
2025
Q4 		$46.8K Buy
+25,000
New +$48K ﹤0.01% 169
2024
Q3 		– Sell
-40,000
Closed -$54.8K – 174
2024
Q2 		$54.8K Hold
40,000
– – ﹤0.01% 165
2024
Q1 		$150K Buy
40,000
+30,000
+300% +$176K 0.01% 160
2023
Q4 		$98.1K Buy
+10,000
New +$81.8K 0.01% 170

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Private Wealth Partners's PACB Position: Q1 2026 in Review

Private Wealth Partners held its Pacific Biosciences (PACB) position steady in Q1 2026 at 25,000 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #169.

Private Wealth Partners first reported a position in PACB in Q4 2023 and has held it in 5 quarters since. The position peaked at $150K in Q1 2024. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Private Wealth Partners held 25,000 shares of Pacific Biosciences worth $33K as of Q1 2026.
  • Private Wealth Partners left its Pacific Biosciences share count unchanged in Q1 2026.
  • Pacific Biosciences made up ﹤0.01% of Private Wealth Partners's portfolio in Q1 2026, its #169 holding.
  • Private Wealth Partners first reported a position in Pacific Biosciences in Q4 2023 and has held it in 5 quarters since.
  • Private Wealth Partners's Pacific Biosciences position peaked at $150K in Q1 2024.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Private Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.